Subthreshold splenic nerve stimulation prevents myocardial Ischemia-Reperfusion injury via neuroimmunomodulation of proinflammatory factor levels

• DOI: 10.1016/j.intimp.2022.109522
• Publication Date: 2022-12-08T05:06:03Z
• Authors: Xiaoxing Jin; Xiaofei Wang; Ji Sun; Wuping Tan; Guocheng Zhang; Jiapeng Han; Mengjie Xie; Liping Zhou; Zhiyao Yu; Tianyou Xu; Changyi Wang; Yueyi Wang; Xiaoya Zhou; Hong Jiang
• Keywords: Rats, Sprague-Dawley; 0301 basic medicine; 03 medical and health sciences; Neuroimmunomodulation; Myocardium; Animals; Myocardial Reperfusion Injury; Heart; Rats; 3. Good health

Clinical outcomes following myocardial ischemia-reperfusion (I/R) injury are strongly related to the intensity and duration of inflammation. The splenic nerve (SpN) is indispensable for the anti-inflammatory reflex. This study aimed to investigate whether splenic nerve stimulation (SpNS) plays a cardioprotective role in myocardial I/R injury and the potential underlying mechanism.Sprague-Dawley rats were randomly divided into four groups: sham group, I/R group, SpNS group, and I/R plus SpNS group. The highest SpNS intensity that did not influence heart rate was identified, and SpNS at this intensity was used as the subthreshold stimulus. Continuous subthreshold SpNS was applied for 1 h before ligation of the left coronary artery for 45 min. After 72 h of reperfusion, samples were collected for analysis.SpN activity and splenic concentrations of cholinergic anti-inflammatory pathway (CAP)-related neurotransmitters were significantly increased by SpNS. The infarct size, oxidative stress, sympathetic tone, and the levels of proinflammatory cytokines, including TNF-α, IL-1β, and IL-6, were significantly reduced in rats subjected to subthreshold SpNS after myocardial I/R injury compared with those subjected to I/R injury alone.Subthreshold SpNS ameliorates myocardial damage, the inflammatory response, and cardiac remodelling induced by myocardial I/R injury via neuroimmunomodulation of proinflammatory factor levels. SpNS is a potential therapeutic strategy for the treatment of myocardial I/R injury.